Why the study?
Does DOCA-salt treatment alter angiotensin II receptor binding in brain nuclei of uninephrectomized male Wistar-Kyoto rats?
Does DOCA-salt treatment alter angiotensin II receptor binding in brain nuclei of uninephrectomized male Wistar-Kyoto rats?
Increased angiotensin II receptors in specific brain areas may contribute to the pathophysiology of mineralocorticoid-salt experimental hypertension.
No takes yet. Share an insight, caveat, or question.
Does not alter clinical hypertension care; leaves open whether brain ANG II receptor upregulation drives mineralocorticoid hypertension in humans.
Gutkind et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: